NUCLEOLIN and breast cancer: We have also recently demonstrated that reduced expression of nucleolin (NCL), a regulator of RNA polymerase I activity finely regulating ribosome production, is associated with poor prognosis in breast cancer, supporting a relationship between reduced ribosome biogenesis and cancer outcome [24].